Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Laparoscopic surgery for renal cell carcinoma.

Waleed A Hasan1, Sidney C Abreu, Inderbir S Gill

  • 1Section of Laparoscopic and Minimally Invasive Surgery, Glickman Urological Institute, Cleveland Clinic Foundation, Ohio 44195, USA. hasanw@ccf.org

Expert Review of Anticancer Therapy
|December 23, 2003
PubMed
Summary

Minimally invasive laparoscopic surgery is increasingly used for renal cell carcinoma management, offering reduced recovery times and improved patient outcomes. This approach is becoming a standard treatment, reserving open surgery for specific complex cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study.

Urologic oncology·2021
Same author

Outcomes of Robot-assisted Partial Nephrectomy for Clinical T3a Renal Masses: A Multicenter Analysis.

European urology focus·2020
Same author

Renal cancer with extensive level IV intracardiac tumour thrombus removed by robot.

Lancet (London, England)·2020
Same author

Multiparametric magnetic resonance imaging facilitates reclassification during active surveillance for prostate cancer.

BJU international·2020
Same author

Timing, Patterns and Predictors of 90-Day Readmission Rate after Robotic Radical Cystectomy.

The Journal of urology·2020
Same author

Web search queries and prostate cancer.

The Lancet. Oncology·2020

Area of Science:

  • Urology
  • Minimally Invasive Surgery
  • Oncology

Background:

  • Renal cell carcinoma (RCC) management is evolving with new minimally invasive technologies.
  • Laparoscopy is emerging as a key technique for tumor destruction and resection in RCC.
  • Current laparoscopic modalities include radical nephrectomy, partial nephrectomy, cryoablation, and radiofrequency ablation.

Purpose of the Study:

  • To provide an update on laparoscopic surgery for renal cell carcinoma (RCC).
  • To describe current indications, contraindications, perioperative data, complications, and oncological outcomes for laparoscopic RCC procedures.
  • To evaluate the expanding role of laparoscopy in managing increasingly complex renal tumors.

Main Methods:

  • Review of current laparoscopic techniques for renal cell carcinoma.

Related Experiment Videos

  • Analysis of perioperative data, complications, and oncological outcomes.
  • Discussion of laparoscopic access (retroperitoneal and transperitoneal) and preservation of renal function.

    • Main Results:

    • Laparoscopic approaches are being applied to larger and more complex renal lesions with promising results.
    • Initial reports focused on highly selected patients, but experience is expanding.
    • The goal of complete tumor destruction with maximal nephron preservation is achievable.

    Conclusions:

    • Laparoscopic surgery is poised to become a major treatment option for renal cell carcinoma.
    • Open surgery will likely be reserved for specific indications.
    • Continued advancements in minimally invasive techniques are expected to improve RCC patient care.